Stockscreener 앱 받기
0.1445
3.38%
0.00525
전일 마감가:
$0.1392
열려 있는:
$0.1562
하루 거래량:
115.02M
Relative Volume:
2.40
시가총액:
$8.06M
수익:
-
순이익/손실:
$-31.39M
주가수익비율:
-0.172
EPS:
-0.84
순현금흐름:
$-18.45M
1주 성능:
-19.16%
1개월 성능:
-95.33%
6개월 성능:
-90.89%
1년 성능:
-89.18%
1일 변동 폭
$0.1399
$0.158
1주일 범위
$0.1348
$0.1697
52주 변동 폭
$0.1251
$4.5499
Quince Therapeutics Inc Stock (QNCX) Company Profile
명칭
Quince Therapeutics Inc
전화
415-910-5717
주소
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Compare QNCX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
0.1447 | 7.75M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.54 | 123.82B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
788.85 | 81.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
838.07 | 52.00B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.14 | 44.14B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
353.85 | 40.83B | 4.98B | 69.60M | 525.67M | 0.5198 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-08-05 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-03-24 | 개시 | Oppenheimer | Outperform |
Quince Therapeutics Inc 주식(QNCX)의 최신 뉴스
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
What Does the Market Think About Quince Therapeutics Inc? - Benzinga
Can Quince Therapeutics Inc. stock surprise with earnings upsideJuly 2025 WrapUp & Consistent Return Investment Signals - mfd.ru
Published on: 2026-02-20 10:05:26 - mfd.ru
Why is QNCX stock up 60% pre-market after a near-total wipeout? - MSN
What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours - Sahm
Market Overview: What is the long term forecast for Warner Music Group Corp stock2025 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
Quince Therapeutics stock plunges as filing shows reverse merger plans, bankruptcy risks - MSN
What sparked Quince Therapeutics (QNCX) stock to rise 53% after hours - MSN
Sell Signal: Is now the right time to enter Quince Therapeutics IncEarnings Overview Report & Smart Money Movement Tracker - baoquankhu1.vn
Quince Therapeutics Pursues Reverse Merger Amid Restructuring Effort - The Globe and Mail
Quince Therapeutics Stock Plunges As Filing Shows Reverse Merger Plans, Bankruptcy Risks - Sahm
3 Penny Stocks to Watch Now, 2/13/26 - TipRanks
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Quince Therapeutics engages LifeSci Capital for strategic alternatives - marketscreener.com
Quince Therapeutics Inc (QNCX) Stock Price, Quote, News & History - Benzinga
Quince Therapeutics stock plummets after revealing strategic alternatives By Investing.com - Investing.com India
Quince Therapeutics stock plummets after revealing strategic alternatives - Investing.com
Quince TherapeuticsOn Feb 9, Engaged Lifesci Capital For Strategic AlternativesSEC Filing - TradingView
Best Penny Stocks To Watch Now – February 10th - Defense World
Small Cap Stocks To Follow Now – February 10th - Defense World
Does Quince Therapeutics Inc. align with a passive investing strategyTrade Entry Summary & Free Weekly Watchlist of Top Performers - mfd.ru
Quince Therapeutics Stock Extends Rally On Strategic Review - Benzinga
Quince Therapeutics (QNCX) Stock Erupts 300% as Buyout Rumors Emerge - MEXC
Quince Therapeutics (QNCX) Stock Surges 300% on Strategic Alternative Plans - parameter.io
QNCX Stock Price and Chart — NASDAQ:QNCX - TradingView
Quince Therapeutics (QNCX) Stock: What’s Behind the 300% Rally? - CoinCentral
Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive - TechStock²
Quince Therapeutics, Spotify, S&P Global, Intel And Datadog: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Quince Therapeutics Stock Explodes 300% On Strategic Review - Benzinga
Why is Quince Therapeutics stock soaring Tuesday? - MSN
QNCX (Quince Therapeutics) NASDAQ intraday up 182.82% to $0.39: watch strategic-review momentum - Meyka
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why Is QNCX Stock Up 60% Pre-Market After A Near-Total Wipeout? - Mena FN
Why Is Quince Therapeutics Stock Soaring Tuesday? - Benzinga
Quince Therapeutics (QNCX) stock slides before the bell after LifeSci Capital deal review move - TechStock²
Quince Therapeutics Exploring Strategic Alternatives; Stock Soars - Nasdaq
Quince Therapeutics Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Alternatives - PharmiWeb.com
Quince Therapeutics stock soars after engaging LifeSci Capital as advisor By Investing.com - Investing.com Nigeria
Quince Therapeutics stock soars after engaging LifeSci Capital as advisor - Investing.com
Fed Meeting: What is Quince Therapeutics Incs debt to equity ratio2025 AllTime Highs & Fast Gain Swing Alerts - baoquankhu1.vn
Quince Therapeutics Announces Significant Board of Directors Resignations - The Globe and Mail
Quince stock plunges 95% following failed clinical trial for inherited childhood disease - The Business Journals
Quince Therapeutics’ stock crashes on Phase III ataxia-telangiectasia failure - Clinical Trials Arena
Quince Therapeutics Inc (QNCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.73%
0.63%
자본화:
|
볼륨(24시간):